• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The invention relates to a medicament pack comprising at least one blister (1) comprising a base body (2) with bulges (3) for receiving medicaments (5) and an electrically and / or magnetically conductive foil (4) which is pressed onto the base body (2). is applied flat and the bulges (3) closes, so that between the bulges (3) and the film (4) closed cavities (6) for the drugs (5) are formed in the cavities (6) located drugs (5), in particular in the form of tablets, a packaging unit (7) for receiving the at least one blister (1) of flat material comprising a number of boundary surfaces, in particular in the form of a folding box, wherein on an interface (9) of the packaging unit (7) an antenna ( 8) is arranged.
    公开号:AT512406A4
    申请号:T962012
    申请日:2012-01-25
    公开日:2013-08-15
    发明作者:Gernot Dipl Ing Schmid；Manfred Dipl Ing Bammer
    申请人:Ait Austrian Inst Technology；Seibersdorf Labor Gmbh；
    IPC主号:
    专利说明:

    25/01/2012 15:35 WILDHACK JELLINEK 53424535 NUM178 D04 • »·································································································· * · * · «« «* * * * * *« «* * ·· ··» »^ * *« * *
    The invention relates to a medicament pack according to the preamble of patent claim 1. Furthermore, the invention relates to a method for testing the authenticity of a medicament pack according to the preamble of patent claim 11.
    Particularly with expensive medicines, there is the problem that the authenticity of medicines must be made comprehensible in order to ensure the proper treatment of patients with the respective medicaments, as well as the safe use of the respective medicaments by the patient.
    OBJECT OF THE INVENTION It is to create a medicament pack with which a check of the authenticity of the drug can be checked together with the pack.
    Another object of the invention is to provide a method for easy authentication of such a drug package available.
    The invention relates to a medicament package comprising - at least one blister comprising a base body with bulges for receiving medicaments and an electrically and / or magnetically conductive foil, the invention solves this problem in a medicament pack of the type mentioned above with the features of the characterizing part of patent claim 1. which is applied flat on the body and the Auswöibungen closes, so that between the bulges and the film completed cavities are formed for the drugs, - located in the cavities drugs, especially in the form of tablets, - a packaging unit for receiving the at least one blister flat material comprising a number of boundary surfaces, in particular in the form of a carton. According to the invention, an antenna is arranged on a boundary surface of the packaging unit.
    Such a drug package has a good interface for wireless communication with an external Datenkommunikatkmsgerät, with a secure and error-free data transmission is ensured with the external data communication device.
    Furthermore, it can be provided that the antenna is arranged on the boundary surface of the packaging unit, which is furthest away from the film. This 25/01/2012 15:37
    No .: R323 P.004 / 021 25/01/2012 15:35 UILDHACK JELLINEK 53424535 005 NUM178 «4« · ♦% ··
    t the data transmission between the antenna and an external data communication device is further improved.
    Alternatively or additionally, it may be provided that the antenna is arranged along the peripheral edge of the boundary surface, which is furthest away from the film. As a result of this measure, a particularly large area is available for the data transmission, so that the specific position plays a rather subordinate role for the external data communication device.
    In order to achieve a simple production of the packaging, it can be provided that the antenna is arranged on the inside of the boundary surface of the packaging unit, which is furthest away from the film, wherein the antenna is arranged in particular on an adhesive film or printed.
    To be particularly difficult to manipulate or to fake
    To provide drug package can be provided that the antenna is embedded in the packaging unit, poured, integrated or printed by means of electrically conductive paste or paint on the packaging unit.
    In order to easily ensure an authenticity check, a control chip may be provided which has connections for connection to the antenna. The control chip drives the antenna for communication with the external data communication device.
    In order to achieve an improved transmission, provision can be made for an enclosed leaflet to bear against the boundary surface on which the antennas are arranged. The leaflet serves as a spacer between the
    Boundary surface and the foil. The large distance between the boundary surface and the foil improves the communication between the antenna as well as the control chip and the external data communication device.
    To facilitate handling of the respective drug package as well as to achieve a more stable data communication connection, a further antenna may be provided, which is arranged on the boundary surface opposite the antenna supporting the boundary surface. 25/01/2012 15:38
    No .: R323 P.005 / 021 25/01/2012 15:35 WILDHACK JELLINEK 4 53424535 NUM178 006 »t * ··· ·· * ··« ·
    For this purpose, it can also be provided that a further control chip is provided and the further antenna is connected to the further control chip or that the antenna and the further antenna are connected to the control chip.
    To check the authenticity of the drug can be provided that in the control chip a unique, exclusively for the respective control chip code is stored, which optionally on a control chip and on a control unit arranged on the same control chip another code is stored.
    Furthermore, the invention relates to a method for checking the authenticity of a drug package according to the invention, wherein a database with valid codes is stored on a server. According to the invention, the code stored on the control chip or the further control chip is read out with a data communication device and transmitted to the server, possibly encrypted, that the server checks whether the code transmitted to it is stored in the database, and that the result of the check is transmitted to the data communication device and displayed by the latter if necessary. As a result, a check of the authenticity can be carried out in a simple manner, wherein the code stored in the medicament pack is not visible to the user.
    In order to ensure improved security, it can be provided that another code, if appropriate in the form of a number or a barcode, is printed on the medicament package, the valid codes and the packaging units provided with these codes being included in the database of the server further codes are stored. It is further provided that in addition to the code stored on the control chip and the printed on the packaging units code is determined by the data communication device that both the code and the other code are transmitted to the server, that is checked whether the code in the database the server is stored and the other code is associated with the code in the database, and that the result of the review is transmitted to the data communication device and displayed by the latter if necessary.
    In order to exclude the authorization to obtain an authentication of the respective package to unauthorized persons, it may be provided that a person code characterizing the patient and / or the pharmacist and / or the prescribing physician is determined during or before the dispensing of the medication package to the patient 25/01 / 2012 15:38
    No .: R323 P. 006/021 25/01/2012 15:35 U1LDHACK JELLINEK - > 53424535 D07 NUM178 «· 4« · # * * * l «« f »·· β * · ♦ ♦ * • ···················································»
    * ·· * ·· " '*' * * * * * I and transmitted to the server and assigned to the respective code stored on the control chip or the further control chip of the drug package wild that queried before the authenticity request a Personenoode of Datenkommunlcationsgerät and by the respective person is entered in the data communication device that the personal code is transmitted together with the stored on the control chip or the other control chip code, and optionally with the other code to the server that is checked before performing further checks, whether the code in the database of the Server is stored and the personal code is associated with the code in the database, and in the event a message of lack of authorization is transmitted to the data communication device and another query is aborted.
    For easy handling of an authentication by the respective user, it may be provided that the personal code characterizing the respective user is stored on a personalized chip card, and the personal code is read out from the chip card.
    A preferred embodiment of the invention is illustrated in more detail below with reference to the drawing figures. Fig. 1 shows the preferred embodiment of a drug package according to the invention obliquely from above. Fig. 2 shows the illustrated in Fig. 1 preferred embodiment of a drug package according to the invention from the side, Fig. 3 shows an adhesive label with an antenna and a control chip. Fig. 4 shows a detail of the Ausführungsfbrm shown in Fig. 1 and the arrangement of the adhesive label. Fig. 5 shows an alternative to the embodiment of the drug package illustrated in Fig. 4, Fig. 6 shows a further alternative embodiment of the invention with two antennas without the blisters. Fig. 7 shows the embodiment shown in Fig. 6 in side view with Blistem. Fig. 8 shows schematically the transfer of data between the drug package, a data communication device and a server.
    In Fig. 1, a drug package is shown containing two blisters 1 and a packaging unit 7 for receiving the two blisters 1. Of course, it is possible that only one or even more than two blisters 1 are located in the packaging unit 7. In addition, typically in the packaging unit 7, a folded Beipeckzettel 13 are included (Fig. 2). 25/01/2012 15:39
    No .: R323 P.007 / 021 25/01/2012 15:35 NUM178 (708 WILDHACK JELUNEK 4 53424535 4 Φ ·· · · 4 0
    The two blisters 1 each comprise a main body 2 with bulges 3 for receiving medicaments 5. The main body 2 may consist of a molded plastic film or a plastic-metal composite foil. The drugs 5 are in the concrete Ausfektionsbeispiel tablets or capsules. The blisters 1 are usually constructed equal to each other. Furthermore, each blister 1 in each case has an electrically and / or magnetically conductive foil 4. An advantage of such a blister 1 is a particularly good storage ability of the medicaments and the guarantee of a high tightness of the cavities 6 formed by the bulges 3 and the film 4.
    The main body 2 of the BJister 1 may itself consist of a metal-plastic composite film, wherein this composite film is typically somewhat thicker than the sealing film. This is mainly intended for packaging for medicines that require a special sunscreen.
    The authenticity check is carried out in such a way that an antenna 8, which is connected to a control chip 12, is arranged on the medicament pack. In the control chip 12, a coded certificate is stored, this is in the present case a string or sequence of numbers, which is determined in the production of the control chip 12 and is known only to the manufacturer or a manufacturer appointed Zerfifizierer. The string or sequence of numbers is read out via an external data communication device 17 (FIG. 8) and transmitted to the manufacturer or certifier, for example via the Internet, which possibly confirms the authenticity.
    The problem, however, is that the electrically and / or magnetically conductive foil 4 or optionally also the electrically and / or magnetically conductive base body 2 weakens or shields electrical and / or magnetic fields and thus a simple authenticity check by means of electromagnetic radio waves or magnetic and / or or electrical coupling between antenna 6 and external
    Data communication device 17, such as in NFC, makes it difficult or impossible. Electromagnetic waves emitted by an external data communication device 17 or electric and / or magnetic fields generated by an external data communication device 17 are shielded or weakened by the film 4 of the blister 1 or blisters 1, so that a test for authenticity impossible or difficult. The power supply of the control chip 12 via the radiated from the external data communication device 17 electromagnetic energy. 25/01/2012 15:39
    Nr .: R323 P.008 / 021 25/01/2012 15:35 WILDHACK JELLINEK + 53424535 009 NUM178 ···························································································· * · O
    In order nevertheless to obtain a good reception, as shown in FIGS. 1 and 2, an antenna 6 is arranged on a boundary surface 9 of the packaging unit 7. In the present case, it is ensured by the special insertion of the blister 1 into the packaging unit 7 that the antenna 8 adjoins the one
    Boundary surface 9 of the packaging unit 7 is arranged, which is furthest away from the film 4. As a result, an electromagnetic data transmission between the antenna 8 and an external data communication device 17 is possible without the electromagnetic waves or electrical and / or magnetic fields used for communication being shielded or excessively weakened by the foils 4 of the blisters 1. The antenna 8 comprises one or more windings which run along the outer peripheral edge 10 of a boundary surface 9 of the packaging unit 7.
    The distance between the foil 4 and the antenna 8 is determined by the in FIG. 2, so that the transmission of data between the antenna 8 and the external data communication device 17 is further improved by the arrangement shown in FIG. The leaflet 13 is applied to the boundary surface 9 of the packaging unit 7, on which the antenna 8 is arranged.
    Hg. 3 shows an adhesive film 11 on which an antenna 8 and the control chip 12 are applied. The adhesive film 11 is stuck in the preparation of the drug package, as shown in Fig. 4, on the inside of the boundary surface 9, wherein the antenna 8 in the region of the inner peripheral edge 10 of the packaging unit 7 extends. The arrangement of the adhesive film 11 inside the packaging unit 7, the risk of destruction of the antenna 8 or the control chip 12 and the risk of detachment of the adhesive film 11 is largely avoided.
    As an alternative to the embodiment shown in FIG. 4, as shown in FIG. 5, it may also be provided that the antenna 8 is embedded, cast in or integrated in the packaging unit 7. In this exemplary embodiment, the packaging unit 7 is made of plastic, the antenna 8 and the control chip 12 being cast into the body of the packaging unit 7. Alternatively, the antenna 8 and the control chip 12 can also be integrated directly into the carton during the production of a packaging unit 7 made as a carton. Furthermore, the antenna 8 can be printed on the packaging unit 7 by means of electrically conductive paste or ink. 25/01/2012 15:39
    No .: R323 P.009 / 021
    25/01/2012 15:35 UJILDHACK JELLIMEK »53424535 010 NUM17B» · * * »« · * * fl
    FIG. 6 shows a further alternative embodiment of the invention, with a view to achieving as little error-prone robust communication between the control chip 12 and the external data communication device.
    At the boundary surface 9 opposite another boundary surface 14, a further antenna 15 is arranged. This further antenna 15 is connected to a further control chip 16. Each antenna 8,15 is thus each connected to a control chip 12,16. The antenna 8 is connected to the control chip 12, the further antenna 15 is connected to the further control chip 16. In the present case, the control chip 12 and the further control chip 16 are identical and provided with a different code, which is transmitted to the external data communication device 17 on request. But it is also possible that each control chip is provided with its own code.
    By virtue of this measure, it is thus possible to apply the external data communication device 17 to each of the boundary surfaces 9, 14 provided with antennas 6, 15 and to one of the two antennas 8, 15 and to the control chips 12, 16 connected to the antennas 8, 15 to connect in data connection and to read the respective code.
    If the film 4 or the main body 2 of a blister 1 located in the packaging unit 7 now completely shields the flux penetrating one of the antennas 8, 15, it may optionally be connected to the respective other antenna 15, 8
    Data communication connection can be achieved and thus data from the respective control chip 12, 16 are transmitted to the external data communication device 17. It is also of considerable advantage here that the use of two opposing antennas 8.15 does not cause the blisters 1 to be "in a special way". must be inserted or arranged to an advantageous
    Data communication connection between the data communication device 17 and at least one of the antennas 8,15 reach.
    Furthermore, it can alternatively be provided that only one control chip 12 is provided, which is connected to both antennas 8, 15. In Fig. 7, the further embodiment of the invention shown in Fig. 6 with two blisters 1 is shown in side view. The two blisters 1 lie with the films 4 to each other. In the present case, they are arranged so that the foils 4 are as far as possible from the respectively nearest antenna 6, 15. 25/01/2012 15:40
    Nr .: R323 P. 010/021 25/01/2012 15:35 WILDHACK JELLINEK 53424535 (711 NUM178 * · »fr * *« · »» «» m · · · «» # »« «v · * · ·
    It is also possible that the position and arrangement of the blisters 1 in the interior of the packaging unit 7 is different, whereby one of the two antennas 8, 15 may also be shielded by a foil 4 of one of the blisters 1. In such a case, there is a possibility that the external data communication device 17 enters data communication with the unshielded antenna 8, 15.
    FIG. 8 shows the examination of the authenticity of the packaging unit 7 with a data communication device 17 which is connected to a server 18. The data communication device 17 itself is either authorized by the drug manufacturer or is a standard data communication device 17, for example a mobile phone, on which runs a software application authorized by the drug manufacturer.
    In the control chip 12 or in the control chips 12, 16, the manufacturer stores a unique, in particular secret, code known only to the manufacturer. Alternatively, different codes for each control chip 12 can be stored separately on this.
    In addition, another code 20 can be visibly printed on the Verpackungseinheft 7. The unambiguous assignment of packaging unit 7 and Steuerchtp 12 also results in a clear association between the secret and the printed on the box code, which is known only to the manufacturer.
    The user brings the data communication device 17 in the vicinity of the packaging unit 7, whereby the code stored in the control chip 12, 16 is automatically read by the data communication device 17, in particular the software application running thereon. This code is encrypted by the data communication device 17, in particular on the software application running thereon, transmitted to the server 16 under control of the manufacturer or a trusted third party. If appropriate, the user is prompted by the data communication device 17, in particular the software application running on it, to enter the additional code that is visibly printed on the packaging unit 7.
    It can be provided, for example, as a further code 2G a bar code which is digitally photographed by means of the data communication device 17 and then decoded 25/01/2012 15:40
    No .: R323 P.011 / 021 25/01/2012 15:35 NUM17e D12 WILDHACK JELLINEK · »53424535 ··········································· ··· · «« | Is transmitted to the server 18 together with the code stored on the memory chip 12, 16.
    According to another alternative, instead of the manual input, the transmission of a code printed in the form of numbers can take place in that these numbers are digitally photographed by means of the data communication device 17 and subsequently determined by character recognition.
    The server 18 determines whether the code stored on the control chip 12, 16 is valid and, if appropriate, whether the association between the code stored on the control chip 12, 16 and the code printed on the packaging unit 7 is correct. The additional use of a printed on the packaging unit 7 or otherwise supplied with the drug package codes increases the security against counterfeiting. The result of the check is returned by the server 18 to the data communication device 17.
    In order to enable the above-mentioned review only a limited circle of authorized users, such as only the doctor, pharmacist or the patient, it can also be provided that authenticate the respective user before initializing the check on the data communication device 17 and / or the server 18 got to. This can be done for example via a wirelessly readable chip card, such as the e-card. On this chip card, a personal code assigned to the respective user is stored, which is transmitted to the server 18 together with the code of the medicament pack during the first authentication and is assigned to the code of the respective medicament pack in the database 19 of the server 18. For example, when dispensing the medicine pack, the pharmacist may transmit his or her own personal code, the personal code of the prescribing physician, and the personal code of the particular patient to the server so that only the prescribing physician, the pharmacist himself and the patient perform an authenticity check allowed to.
    If an authenticity check is now carried out, for example by the patient, then his data communication device 17 transmits the code stored on the control chip 12 or the further control chip 12, optionally the further code 20 printed on the medicament pack, and finally his personal code to the server 18.
    If the personal code is assigned to the respective code of the control chip 12 or the further control chip 16, the patient is entitled to the result of the authentication 25/01/2012 15:41
    No .: R323 P.012 / 021 25/01/2012 15:35 Ul ILDHACK JELLINEK »53424535 013 NUM178 10 to learn, it is now checked by the server 18 whether the code of the control chip 12 or the other control chip 16 the other code 20th zugeordrvet Ist. The patient is sent a certificate of the authenticity of the drug package.
    On the other hand, if the personal code is not associated with the respective code of the control chip 12 or the further control chip 16, then it only receives the notification that it is not authorized to check the authenticity of the medication package. 25/01/2012 15:41
    No .: R323 P.013 / 021
    权利要求:
    Claims (14)
    [1]
    25/01/2012 15:35 NUM178 014 LJILDmCK JELL1NEK · * 53424535 · »ft» ·· * · * · ** · »· *« * ·· «·· * ·» «* · *** * · • Claims 1. A medicament package comprising at least one blister (1) comprising a main body (2) with Bulges (3) for receiving medicaments (5) and an electrically and / or magnetically conductive foil (4) which is applied flatly on the base body (2) and the bulges (3) closes, so that between the bulges {3) and cavities (6) for the medicaments (5) are formed in the film, - medicaments (5) located in the cavities (6), in particular in the form of tablets, - a packaging unit (7) for receiving the at least one blister (1) of sheet material comprising a number of boundary surfaces, in particular in the form of a carton, characterized in that at a boundary surface (9) of the packaging unit (7) an antenna (8) is arranged.
    [2]
    2. medicament packaging according to claim 1, characterized in that the antenna (8) on that boundary surface (9) of the packaging unit (7) is arranged, which is furthest away from the film (4).
    [3]
    3. medicament pack according to claim 1 or 2, characterized in that the antenna (8) along the peripheral edge (10) of the boundary surface (9) is arranged, which is the furthest away from the film (4).
    [4]
    4. medicament packaging according to one of the preceding claims, characterized in that the antenna (8) on the inside of the boundary surface (9) of the packaging unit (7) is arranged, which is furthest away from the film (4), wherein the antenna ( 8) is arranged in particular on an adhesive film (11) or is printed on the adhesive film (11).
    [5]
    5. medicament pack according to one of the preceding claims, characterized in that the antenna (8) embedded in the packaging unit (7), poured, integrated or printed by means of electrically lertfähiger paste or paint on the packaging unit
    [6]
    6. medicament pack according to one of the preceding claims, characterized by a control chip (12) having connections for connection to the antenna (8). 25/01/2012 15:41 No .: R323 P.014 / 021 25/01/2012 15:35 WILDHACK JELLINEK 53424535 NUM178 D15 4t 44 4 · * · · 4t · * • * 4 4 4 4 · 4 · * # 4 t · 4 4 · · »• f · 4 · ·» 4 4 *
    [7]
    7. medicament pack according to one of the preceding claims, characterized in that a leaflet (13) on the inside abuts the boundary surface (9) on which the antenna (8) is arranged.
    [8]
    8. medicament pack according to one of the preceding claims, characterized in that a further antenna is provided, which is arranged on the said antenna (8) carrying the boundary surface (9) opposite boundary surface.
    [9]
    9. medicament pack according to claim 8, characterized in that a further control chip (16) is provided and the further antenna is connected to the further control chip (16) or that the antenna (8) and the further antenna connected to the control chip (12) are.
    [10]
    10. medicament pack according to one of the preceding claims, characterized in that for verifying the authenticity of the drug in the control chip (12) a unique, exclusively for the respective control chip (12) assigned code is stored, optionally on a control chip (12) and on a further control chip (16) arranged on the medicament pack stores a further unique code.
    [11]
    11. A method for checking the authenticity of a drug package according to one of claims 6 to 10, wherein on a server (18) a database (19) is stored with valid codes, characterized in that • on the control chip (12) or the other Control chip (16) stored code with a data communication device (17) is read and to the server (18), optionally encrypted, is transmitted, - that is checked by the server (18), whether the transmitted to him code in the database (19) Is stored, and • that the result of the review to the data communication device (17) is transmitted and displayed by the latter if necessary.
    [12]
    12. The method of claim 11, wherein on the drug package (7) another code (20), optionally in the form of a number or a bar code, is printed, wherein in the database (19) of the server (18) the valid codes and the are stored on the provided with these codes packaging units (7) associated additional codes. 25/01/2012 15:42 No.: R323 P.015 / 021 25/01/2012 15:35 WILDHACK JELL1NEK * 53424535 NUM179 Dl6 ft ft ff fl • ·· t · ftf · • fl I · · · M • itf · · · · · ttt · m ...... tj · characterized in that - in addition to the code stored on the control chip (12, 16), the code printed on the packaging unit (7) is also available from the data communication device (17) is determined - that both the code and the other code to the server (1B) are transmitted. , checking that the code is stored in the database (19) of the server (16) and the further code is associated with the code in the database (19), and - that the result of the check is transmitted to the data communication device (17) and may be displayed by it.
    [13]
    13. The method according to any one of claims 11 or 12, characterized in that - determined during or before the dispensing of the drug package to the patient a patient and / or the pharmacist and / or the prescribing physician characterizing personal code and to the server (18) is communicated and assigned to the respective code stored on the control chip (12) or the further control chip (16) of the medicament package, - that prior to interrogation of the authenticity a personal code is obtained from the data uni cation device (17) and queried by the respective person at the data communication device ( 17) is input, - that the personal code is transmitted together with the on the control chip (12) or the further control chip (16) stored code, and optionally with the other code to the server, - that is checked before carrying out further checks whether the code is stored in the database (19) of the server (18) and the person code the code in de r database (19) is assigned, and otherwise a message of lack of authorization to the data communication device (17) is transmitted and another query is aborted.
    [14]
    14. The method according to any one of claims 11 to 13, characterized in that the user code characterizing the respective user is stored on a personalized chip card, and the personal code is read from the chip card 25/01/2012 15:42 No .: R323 P.016 / 021
    类似技术:
    公开号 | 公开日 | 专利标题
    WO2008135823A1|2008-11-13|Method for medication at a prescribed time, a dispenser and a tape for use with the method, and a closed loop comprising the dispenser and the tape
    EP2296737A1|2011-03-23|Safety system for avoiding wrong use of medicine
    AT512406B1|2013-08-15|MEDICATION PACKAGE
    DE102009018285B4|2015-09-10|Blister pack, evaluation device and method for operating a blister pack arrangement
    DE102012213970A1|2014-05-15|Barrier-free packaging for goods, especially for medicines
    EP3175391A1|2017-06-07|Document with sensor means
    EP2671194B1|2015-09-23|Container and packaging unit
    EP2383705B1|2012-10-31|Forgery-proof blister pack
    EP2160171A2|2010-03-10|System for verifying the integrity of a blister package
    WO2013124150A1|2013-08-29|Method for triggering an action of a device authorised by a paper document
    DE102008000897A1|2009-10-01|Communication method of an electronic health card with a reader
    DE202020103841U1|2021-08-09|Pathogen Treatment Management System
    EP2170242A2|2010-04-07|System for controlling drug intake
    EP3461761A1|2019-04-03|Press-through package
    WO2017036455A2|2017-03-09|Device and method for authenticating and authorizing persons
    WO2009000384A2|2008-12-31|System for controlling drug intake
    EP2210221B1|2014-06-25|Production of a portable data carrier
    DE102012005443A1|2013-09-26|Device for use as attachment on blister package for monitoring removal of medication from blister package, has panel that is divided into multiple fields, whose arrangement corresponds arrangement of removal opening of blister package
    DE102019134447A1|2021-06-17|Method and device for administering a polymedication
    Cho et al.2017|Adapter-based Safety Injection System for Prevention of Wrong Route and Wrong Patient Medication Errors
    EP3699792A1|2020-08-26|Security element and consumption unit with security element and method for securing permissible consumption by the manufacturer
    DE102019128518A1|2021-04-22|Electronic labeling assembly, method of making an electronic labeling assembly, and medicament packaging
    EP3701423B1|2021-10-13|Security label for detecting improper manipulation attempts
    JP2019174923A|2019-10-10|Management method of medicament
    EP3372403B1|2020-04-29|Method and device for producing a document
    同族专利:
    公开号 | 公开日
    EP2806846A1|2014-12-03|
    WO2013110107A1|2013-08-01|
    AT512406B1|2013-08-15|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    JP2002102310A|2000-10-04|2002-04-09|Dainippon Printing Co Ltd|Medicine package with non-contact data carrier, medicine explanatory document and utilizing method for medicine information|
    WO2005081157A1|2004-02-19|2005-09-01|Cypak Ab|Secure data management device and method|
    JP2011187075A|2005-03-28|2011-09-22|Hitachi Information Systems Ltd|Rfid tag system and communication system for the same|
    JP2008084026A|2006-09-27|2008-04-10|Hitachi Information Systems Ltd|Rfid tag system for wallet type package|
    CA2610198A1|2005-06-08|2006-12-14|Nycomed Gmbh|Method for the provision of clinical trial products|
    CA2624297A1|2005-10-18|2007-04-26|Geof Auchinleck|Method and apparatus for managing the administration of medications|
    JPWO2008117544A1|2007-03-28|2010-07-15|日本電気株式会社|Inclusion Management Device, Inclusion Management Device Manufacturing Apparatus, Inclusion Management Device Manufacturing Method, and Inclusion Management Method|
    KR20100098272A|2009-02-27|2010-09-06|이봉수|A packaging box|
    DE102009022850A1|2009-05-27|2010-12-02|Siemens Aktiengesellschaft|Authentication of an RFID tag with an asymmetric cryptography method|AT513652B1|2012-11-15|2015-10-15|Ait Austrian Inst Technology|Apparatus and process for the preparation, dosing and packaging of medicaments|
    DE102013114896B4|2013-12-27|2015-08-27|Schott Ag|Packaging structure and method for the sterile packaging of containers for substances for medical, pharmaceutical or cosmetic applications, as well as methods for the further processing of containers using the packaging structure|
    法律状态:
    2019-09-15| MM01| Lapse because of not paying annual fees|Effective date: 20190125 |
    优先权:
    申请号 | 申请日 | 专利标题
    AT962012A|AT512406B1|2012-01-25|2012-01-25|MEDICATION PACKAGE|AT962012A| AT512406B1|2012-01-25|2012-01-25|MEDICATION PACKAGE|
    PCT/AT2013/050013| WO2013110107A1|2012-01-25|2013-01-16|Medicament packaging|
    EP13702724.9A| EP2806846A1|2012-01-25|2013-01-16|Medicament packaging|
    [返回顶部]